Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Evidence for single nucleotide polymorphisms and their association with bipolar disorder.

Szczepankiewicz A.

Neuropsychiatr Dis Treat. 2013;9:1573-82. doi: 10.2147/NDT.S28117. Epub 2013 Oct 11. Review.

2.

The association of white matter volume in psychotic disorders with genotypic variation in NRG1, MOG and CNP: a voxel-based analysis in affected individuals and their unaffected relatives.

Cannon DM, Walshe M, Dempster E, Collier DA, Marshall N, Bramon E, Murray RM, McDonald C.

Transl Psychiatry. 2012 Oct 9;2:e167. doi: 10.1038/tp.2012.82.

3.

Molecular genetics of the psychosis phenotype.

DeRosse P, Malhotra AK, Lencz T.

Can J Psychiatry. 2012 Jul;57(7):446-53. Review.

4.

Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population.

Moon E, Rollins B, Mesén A, Sequeira A, Myers RM, Akil H, Watson SJ, Barchas J, Jones EG, Schatzberg A, Bunney WE, DeLisi LE, Byerley W, Vawter MP.

Schizophr Res. 2011 Sep;131(1-3):52-7. doi: 10.1016/j.schres.2011.06.024. Epub 2011 Jul 13.

5.

Analysis of a promoter polymorphism in the SMDF neuregulin 1 isoform in Schizophrenia.

Pedrosa E, Nolan KA, Stefanescu R, Herskovits P, Novak T, Zukov I, Stopkova P, Lachman HM.

Neuropsychobiology. 2009;59(4):205-12. doi: 10.1159/000223732. Epub 2009 Jun 10. Erratum in: Neuropsychobiology. 2009;60(2):72. Hershcovitz, Pnina [corrected to Herskovits, Pnina].

6.

Family-based association study of Neuregulin 1 with psychotic bipolar disorder.

Goes FS, Willour VL, Zandi PP, Belmonte PL, MacKinnon DF, Mondimore FM, Schweizer B, Gershon ES, McMahon FJ, Potash JB; Bipolar Disorder Phenome Group; NIMH Genetics Initiative Bipolar Disorder Consortium.

Am J Med Genet B Neuropsychiatr Genet. 2009 Jul 5;150B(5):693-702. doi: 10.1002/ajmg.b.30895.

7.

The genetic deconstruction of psychosis.

Owen MJ, Craddock N, Jablensky A.

Schizophr Bull. 2007 Jul;33(4):905-11. Epub 2007 Jun 5. Review.

8.

Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders.

Roy K, Murtie JC, El-Khodor BF, Edgar N, Sardi SP, Hooks BM, Benoit-Marand M, Chen C, Moore H, O'Donnell P, Brunner D, Corfas G.

Proc Natl Acad Sci U S A. 2007 May 8;104(19):8131-6. Epub 2007 May 1.

9.

Clinical impact of recently detected susceptibility genes for schizophrenia.

Maier W, Zobel A, Kühn KU.

Dialogues Clin Neurosci. 2006;8(1):79-84. Review.

10.

Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology.

Craddock N, O'Donovan MC, Owen MJ.

Schizophr Bull. 2006 Jan;32(1):9-16. Epub 2005 Nov 30. Review.

Supplemental Content

Loading ...
Support Center